142 related articles for article (PubMed ID: 36966389)
1. Efficacy of Mesenchymal Stem Cell Therapy on Lupus Nephritis and Renal Function in Systemic Lupus Erythematosus: A Meta-Analysis.
Xia Y; Ye H; Li K; Shi B; Sun X; Wu J
Clin Invest Med; 2023 Mar; 46(1):E24-35. PubMed ID: 36966389
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
Liu S; Guo YL; Yang JY; Wang W; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study.
Wang D; Li J; Zhang Y; Zhang M; Chen J; Li X; Hu X; Jiang S; Shi S; Sun L
Arthritis Res Ther; 2014 Mar; 16(2):R79. PubMed ID: 24661633
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.
Gu F; Wang D; Zhang H; Feng X; Gilkeson GS; Shi S; Sun L
Clin Rheumatol; 2014 Nov; 33(11):1611-9. PubMed ID: 25119864
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis.
Zhou T; Liao C; Li HY; Lin W; Lin S; Zhong H
Stem Cell Res Ther; 2020 Feb; 11(1):48. PubMed ID: 32019582
[TBL] [Abstract][Full Text] [Related]
6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
7. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
[TBL] [Abstract][Full Text] [Related]
8. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
9. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.
Deng D; Zhang P; Guo Y; Lim TO
Ann Rheum Dis; 2017 Aug; 76(8):1436-1439. PubMed ID: 28478399
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
[TBL] [Abstract][Full Text] [Related]
11. ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
Parodis I; Gokaraju S; Zickert A; Vanarsa K; Zhang T; Habazi D; Botto J; Serdoura Alves C; Giannopoulos P; Larsson A; Svenungsson E; Gunnarsson I; Mohan C
Rheumatology (Oxford); 2020 Sep; 59(9):2237-2249. PubMed ID: 31722419
[TBL] [Abstract][Full Text] [Related]
12. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
13. Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.
Li C; Han Y; Zhang L; Chen Z; Jin M; Sun S
BMC Nephrol; 2022 Aug; 23(1):296. PubMed ID: 36008770
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans.
Chun S; Choi CB; Kim MS; Nam JY; Lee TY; Lee YT; Kim S; Han SB; Bae SC
Lupus; 2022 Sep; 31(10):1245-1253. PubMed ID: 35802867
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis.
Barbado J; Tabera S; Sánchez A; García-Sancho J
Lupus; 2018 Nov; 27(13):2161-2165. PubMed ID: 30290717
[TBL] [Abstract][Full Text] [Related]
16. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.
Sjöwall C; Zickert A; Skogh T; Wetterö J; Gunnarsson I
Arthritis Res Ther; 2009; 11(6):R188. PubMed ID: 20003354
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
20. Long-term renal survival of paediatric patients with lupus nephritis.
Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
